Loss of CYLD accelerates melanoma development and progression in the Tg(Grm1) melanoma mouse model

Selenium-binding protein 1 is down-regulated in malignant melanoma

(2018) Mandy Schott et al.   Oncotarget

BMP6-induced modulation of the tumor micro-milieu

(2018) David Stieglitz et al.   ONCOGENE

Unexpected contribution of lymphatic vessels to promotion of distant metastatic tumor spread

(2018) Qiaoli Ma et al.   Science Advances

Wild type Kirsten rat sarcoma is a novel microRNA-622-regulated therapeutic target for hepatocellular carcinoma and contributes to sorafenib resistance

(2017) Peter Dietrich et al.   GUT

Risk Factors for Lymph Node Metastasis in Western Early Gastric Cancer After Optimal Surgical Treatment

(2017) Marina Alessandra Pereira et al.   JOURNAL OF GASTROINTESTINAL SURGERY

Tumor cell vascular mimicry: Novel targeting opportunity in melanoma

(2016) Mary J.C. Hendrix et al.   PHARMACOLOGY & THERAPEUTICS

Influence of lymphatic endothelial cells on proliferation and invasiveness of esophageal carcinoma cells in vitro and lymphangiogenesis in vivo

(2015) Xu Yang et al.   MEDICAL ONCOLOGY

Structural and functional analysis of cell adhesion and nuclear envelope nano-topography in cell death

(2015) Hyuk-Kwon Kwon et al.   Scientific Reports

Tg(Grm1) transgenic mice: A murine model that mimics spontaneous uveal melanoma in humans?

(2014) Susanne Schiffner et al.   EXPERIMENTAL EYE RESEARCH

STRING v10: protein–protein interaction networks, integrated over the tree of life

(2014) Damian Szklarczyk et al.   NUCLEIC ACIDS RESEARCH

Transcriptome sequencing of melanocytic nevi and melanomas fromGrm1transgenic mice to determine melanoma driver mutations

(2014) Miriam M. de Jel et al.   Pigment Cell & Melanoma Research

Tumor angiogenesis is caused by single melanoma cells in a manner dependent on reactive oxygen species and NF- B

(2013) M. K. Schaafhausen et al.   JOURNAL OF CELL SCIENCE

ADAMTS5 Functions as an Anti-Angiogenic and Anti-Tumorigenic Protein Independent of Its Proteoglycanase Activity

(2012) Saran Kumar et al.   AMERICAN JOURNAL OF PATHOLOGY

Regulation of mGluR1 expression in human melanocytes and melanoma cells

(2012) Hwa Jin Lee et al.   Biochimica et Biophysica Acta-Gene Regulatory Mechanisms

Human RNA Methyltransferase BCDIN3D Regulates MicroRNA Processing

(2012) Blerta Xhemalce et al.   CELL

Highly pigmented Tg(Grm1) mouse melanoma develops non-pigmented melanoma cells in distant metastases

(2012) Susanne Schiffner et al.   EXPERIMENTAL DERMATOLOGY

CYLD Inhibits Melanoma Growth and Progression through Suppression of the JNK/AP-1 and β1-Integrin Signaling Pathways

(2012) Hengning Ke et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Death inducer-obliterator 1 (Dido1) is a BMP target gene and promotes BMP-induced melanoma progression

(2012) S Braig et al.   ONCOGENE

CYLD negatively regulates transforming growth factor-β-signalling via deubiquitinating Akt

(2012) Jae Hyang Lim et al.   Nature Communications

CYLD regulates keratinocyte differentiation and skin cancer progression in humans

(2011) J P Alameda et al.   Cell Death & Disease

CYLD regulates angiogenesis by mediating vascular endothelial cell migration

(2010) J. Gao et al.   BLOOD

Loss of the Tumor Suppressor CYLD Enhances Wnt/β-Catenin Signaling through K63-Linked Ubiquitination of Dvl

(2010) Daniele V.F. Tauriello et al.   MOLECULAR CELL

An inactivating CYLD mutation promotes skin tumor progression by conferring enhanced proliferative, survival and angiogenic properties to epidermal cancer cells

(2010) J P Alameda et al.   ONCOGENE

Down-regulation of CYLD expression by Snail promotes tumor progression in malignant melanoma

(2009) Ramin Massoumi et al.   JOURNAL OF EXPERIMENTAL MEDICINE

The first but not the second thrombospondin type 1 repeat of ADAMTS5 functions as an angiogenesis inhibitor

(2008) Soheila Sharghi-Namini et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS